ADC Therapeutics SA
ADCT
$1.22
$0.108.93%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 63.86% | 5.90% | 25.30% | 21.50% | -233.65% |
| Total Depreciation and Amortization | -6.38% | -9.38% | 3.20% | 16.60% | 26.80% |
| Total Amortization of Deferred Charges | -180.26% | -37.00% | -34.62% | -39.40% | -79.10% |
| Total Other Non-Cash Items | -103.08% | 2.89% | -2.53% | 16.50% | 67.62% |
| Change in Net Operating Assets | 47.41% | 1,944.71% | -195.98% | -130.15% | 111.53% |
| Cash from Operations | 30.92% | 31.71% | 6.12% | -186.48% | 41.00% |
| Capital Expenditure | 72.48% | 67.32% | 97.52% | 47.74% | -52.80% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 72.48% | 67.32% | 97.52% | 47.74% | -119.19% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -16.24% | -- |
| Repurchase of Common Stock | -116,200.00% | -- | -- | -- | 99.93% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -111,900.00% | -351.86% | 35.01% | -16.24% | 99.96% |
| Foreign Exchange rate Adjustments | -325.66% | 346.61% | -80.33% | -148.31% | -37.45% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 26.42% | 30.34% | 78.11% | -178.80% | 41.55% |
